Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 10,739 | 8,717 | 0 | 3,712 | 3,979 |
| Cost of Goods | 1,993 | 1,598 | N/A | 1,351 | 1,327 |
| Gross Profit | 8,746 | 7,119 | N/A | 2,361 | 2,653 |
| Operating Expenses | 9,131 | 8,039 | 0 | 5,564 | 5,646 |
| Operating Income | 608 | -322 | N/A | -2,852 | -2,666 |
| Interest Expense | 1,693 | 1,024 | 0 | 569 | 525 |
| Other Income | -184 | -12 | 0 | -30 | 36 |
| Pre-tax Income | -1,269 | -1,358 | 0 | -3,450 | -3,155 |
| Net Income Continuous | -1,269 | -1,358 | N/A | -3,450 | -3,155 |
| Net Income | $-1,269 | $-1,358 | $N/A | $-3,450 | $-3,155 |
| EPS Basic Total Ops | -1.05 | -1.22 | N/A | -2.33 | -2.15 |
| EPS Basic Continuous Ops | -0.59 | -0.71 | N/A | -1.80 | -1.66 |
| EPS Diluted Total Ops | -1.05 | -1.22 | N/A | -2.33 | -2.15 |
| EPS Diluted Continuous Ops | -0.59 | -0.71 | N/A | -1.80 | -1.66 |
| EBITDA(a) | $1,611 | $92 | $N/A | $-2,629 | $-2,666 |